ArticlePharmaceutics2022

Adalimumab Decorated Nanoparticles Enhance Antibody Stability and Therapeutic Outcome in Epithelial Colitis Targeting.

Markus Ries et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.